Literature DB >> 7693340

A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma.

K Taketa1, Y Endo, C Sekiya, K Tanikawa, T Koji, H Taga, S Satomura, S Matsuura, T Kawai, H Hirai.   

Abstract

Lectin-affinity electrophoretic separation of serum alpha-fetoprotein (AFP) was carried out using AFP Differentiation Kits, which used Lens culinaris agglutinin-A (Kit L) and erythroagglutinating phytohemagglutinin (Kit P). Separated AFP bands were detected with a sensitive antibody-affinity blotting technique and determined quantitatively by densitometry, and the results were expressed as percentages of the intensity of total AFP bands. Sera from 424 patients with acute hepatitis, chronic hepatitis, liver cirrhosis, hepatocellular carcinoma, and extrahepatic tumors were assayed for proportion of AFP present as Lens culinaris agglutinin-A-reactive AFP (AFP-L3) and erythroagglutinating phytohemagglutinin-reactive AFPs (AFP-P4+P5). From the maximum Youden indices determined, cutoff levels were set at 15% for both AFP-L3 and AFP-P4+P5 to discriminate between patients with chronic hepatitis and liver cirrhosis and patients with hepatocellular carcinoma. AFP-L3 and AFP-P4+P5 showed sensitivities of 55.3 and 61.0% at specificities of 93.9% and 82.3%, respectively. Thirty-eight % of tumors that measured less than 20 mm in diameter were positive for AFP-L3 and AFP-P4+P5. AFP-L3 exceeded the cutoff level of 15% 4.0 +/- 4.9 months before detection of hepatocellular carcinomas by imaging techniques with a sensitivity of 48% and a specificity of 81%. Thus, these tests are useful for the early detection of hepatocellular carcinomas in patients with hepatitis or liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693340

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  71 in total

1.  Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C.

Authors:  Richard K Sterling; Elizabeth C Wright; Timothy R Morgan; Leonard B Seeff; John C Hoefs; Adrian M Di Bisceglie; Jules L Dienstag; Anna S Lok
Journal:  Am J Gastroenterol       Date:  2011-09-20       Impact factor: 10.864

2.  Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.

Authors:  S D Ryder
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

3.  Usefulness of ED036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma.

Authors:  R Kuromatsu; M Tanaka; Y Shimauchi; M Shimada; K Tanikawa; K Watanabe; T Yokoo
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 4.  Approaches to the diagnosis of hepatocellular carcinoma.

Authors:  Morris Sherman
Journal:  Curr Gastroenterol Rep       Date:  2005-02

Review 5.  Management of hepatocellular carcinoma in Japan.

Authors:  Kiwamu Okita
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

6.  Increased bisecting and core-fucosylated N-glycans on mutant human amyloid precursor proteins.

Authors:  Keiko Akasaka-Manya; Hiroshi Manya; Yoko Sakurai; Boguslaw S Wojczyk; Steven L Spitalnik; Tamao Endo
Journal:  Glycoconj J       Date:  2008-06-03       Impact factor: 2.916

7.  Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment.

Authors:  Yasushi Tamura; Masato Igarashi; Takeshi Suda; Toshifumi Wakai; Yoshio Shirai; Takeji Umemura; Eiji Tanaka; Satoru Kakizaki; Hitoshi Takagi; Yoichi Hiasa; Morikazu Onji; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2010-07       Impact factor: 3.199

8.  Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.

Authors:  Petr Pompach; Zuzana Brnakova; Miloslav Sanda; Jing Wu; Nathan Edwards; Radoslav Goldman
Journal:  Mol Cell Proteomics       Date:  2013-02-06       Impact factor: 5.911

9.  From the gamma-glutamyl cycle to the glycan cycle: a road with many turns and pleasant surprises.

Authors:  Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

10.  Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat.

Authors:  Meng Fang; Sylviane Dewaele; Yun-Peng Zhao; Peter Stärkel; Valerie Vanhooren; Yue-Ming Chen; Xin Ji; Ming Luo; Bao-Mu Sun; Yves Horsmans; Anne Dell; Stuart M Haslam; Paola Grassi; Claude Libert; Chun-Fang Gao; Cuiying Chitty Chen
Journal:  Mol Cancer       Date:  2010-08-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.